Algernon Pharmaceuticals Inc (AGNPF)

[shell3]

d. Please provide the following information as of the latest practicable date:

i. Number of Beneficial Owners holding at least 100 shares: 1315 as of May 1, 2018

(“Beneficial Owner” shall mean any person who, directly or indirectly has or shares voting power of such security or investment power, which includes the power to dispose, or to direct the disposition of, such security.)

ii. Number of shares in the Public Float: 54,101,523 as of May 1, 2018

(“Public Float” shall mean the total number of unrestricted shares not held directly or indirectly by an officer, director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding, or any Affiliates thereof, or any Immediate Family Members of officers, directors and control persons.)

Directors or Officers
Dr Raj 2,000,000
Dr Constanzo 500,000
CFO Sadhra 762,500

3,262,500 Total of Directors or Officers shares

They own less than 6% of the Outstanding
https://backend.otcmarkets.com/otcapi/company/financial-report/192225/content

Here’s another Quote and Link of the Annual Meeting

NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS AND NOTICE AND ACCESS NOTICE
NOTICE IS HEREBY GIVEN that the annual general meeting (the “Meeting”) of all the holders (“Shareholders”) of Common Shares (the “Shares”) of Breathtec Biomedical, Inc. (the “Corporation”) will be held at Suite 915, 700 West Pender Street, Vancouver, British Columbia, on Wednesday, April 4, 2018 at 10:00 a.m. (Vancouver time), for the following purposes:

1. To table the audited financial statements of the Corporation for the financial year ended August 31, 2017, the accompanying report of the auditors thereon and the related management’s discussion and analysis;

2. To fix the number of directors at three;

3. To elect the directors for the ensuing year;

4. To appoint Smythe LLP, Chartered Professional Accountants, as the auditor of the Corporation for the ensuing year;

5. To ratify and approve the Corporation’s Stock Option Plan, as more particularly described in the Information Circular for the Meeting.

No other matters are contemplated for consideration at the Meeting, however any permitted amendment to or variation of any matter identified in this Notice may properly be considered at the Meeting. The Meeting may also consider the transaction of such other business as may properly come before the Meeting or any adjournment thereof.

https://webfiles.thecse.com/BTH2018AGMNotice.pdf?iaZ0V2rRTI8Ecg2NxD43J6DEaEuFAyF5=

anyone here on the BTHCF Board go to the Meeting? Could have been already decided this NASH

They never Reported the Meeting Results that I have found - Do any of you find the Meeting Results?